Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome

被引:94
作者
Banh, Tonny H. M. [1 ]
Hussain-Shamsy, Neesha [1 ]
Patel, Viral [1 ]
Vasilevska-Ristovska, Jovanka [1 ]
Borges, Karlota [1 ]
Sibbald, Cathryn [1 ]
Lipszyc, Deborah [1 ]
Brooke, Josefina [2 ]
Geary, Denis [2 ,4 ]
Langlois, Valerie [2 ,4 ]
Reddon, Michele [2 ]
Pearl, Rachel [2 ,4 ]
Levin, Leo [2 ,4 ]
Piekut, Monica [2 ]
Licht, Christoph P. B. [2 ,3 ,4 ]
Radhakrishnan, Seetha [2 ,4 ]
Aitken-Menezes, Kimberly [2 ]
Harvey, Elizabeth [2 ,4 ]
Hebert, Diane [2 ,4 ]
Piscione, Tino D. [2 ,4 ]
Parekh, Rulan S. [1 ,2 ,4 ,5 ,6 ]
机构
[1] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada
[2] Hosp Sick Children, Div Nephrol, Toronto, ON, Canada
[3] Hosp Sick Children, Cell Biol Program, Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Hlth Network, Toronto, ON, Canada
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2016年 / 11卷 / 10期
关键词
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STEROID-RESISTANT; RENAL-DISEASE; RISK; CHILDREN; CYCLOPHOSPHAMIDE; RACE; PROGRESSION; VALIDATION; MANAGEMENT;
D O I
10.2215/CJN.00380116
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Ethnic differences in outcomes among children with nephrotic syndrome are unknown. Design, setting, participants, & measurements We conducted a longitudinal study at a single regional pediatric center comparing ethnic differences in incidence from 2001 to 2011 census data and longitudinal outcomes, including relapse rates, time to first relapse, frequently relapsing disease, and use of cyclophosphamide. Among 711 children, 24% were European, 33% were South Asian, 10% were East/Southeast Asian, and 33% were of other origins. Results Over 10 years, the overall incidence increased from 1.99/100,000 to 4.71/100,000 among children ages 1-18 years old. In 2011, South Asians had a higher incidence rate ratio of 6.61 95% confidence interval, 3.16 to 15.1) compared with Europeans. East/Southeast Asians had a similar incidence rate ratio 0.76; 95% confidence interval, 0.13 to 2.94) to Europeans. We determined outcomes in 455 children from the three largest ethnic groups with steroid-sensitive disease over a median of 4 years. South Asian and East/Southeast Asian children had significantly lower odds of frequently relapsing disease at 12 months South Asian: adjusted odds ratio; 0.55; 95% confidence interval, 0.39 to 0.77; East/Southeast Asian: adjusted odds ratio; 0.42; 95% confidence interval, 0.34 to 0.51), fewer subsequent relapses South Asian: adjusted odds ratio; 0.64; 95% confidence interval, 0.50 to 0.81; East/Southeast Asian: adjusted odds ratio; 0.47; 95% confidence interval, 0.24 to 0.91), lower risk of a first relapse South Asian: adjusted hazard ratio, 0.74; 95% confidence interval, 0.67 to 0.83; East/Southeast Asian: adjusted hazard ratio, 0.65; 95% CI, 0.63 to 0.68), and lower use of cyclophosphamide South Asian: adjusted hazard ratio, 0.82; 95% confidence interval, 0.53 to 1.28; East/Southeast Asian: adjusted hazard ratio, 0.54; 95% confidence interval, 0.41 to 0.71) compared with European children. Conclusions Despite the higher incidence among South Asians, South and East/Southeast Asian children have significantly less complicated clinical outcomes compared with Europeans.
引用
收藏
页码:1760 / 1768
页数:9
相关论文
共 44 条
  • [11] Asthma and ethnic minorities: socioeconomic status and beyond
    Forno, Erick
    Celedon, Juan C.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 9 (02) : 154 - 160
  • [12] HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome
    Gbadegesin, Rasheed A.
    Adeyemo, Adebowale
    Webb, Nicholas J. A.
    Greenbaum, Larry A.
    Abeyagunawardena, Asiri
    Thalgahagoda, Shenal
    Kale, Arundhati
    Gipson, Debbie
    Srivastava, Tarak
    Lin, Jen-Jar
    Chand, Deepa
    Hunley, Tracy E.
    Brophy, Patrick D.
    Bagga, Arvind
    Sinha, Aditi
    Rheault, Michelle N.
    Ghali, Joanna
    Nicholls, Kathy
    Abraham, Elizabeth
    Janjua, Halima S.
    Omoloja, Abiodun
    Barletta, Gina-Marie
    Cai, Yi
    Milford, David D.
    O'Brien, Catherine
    Awan, Atif
    Belostotsky, Vladimir
    Smoyer, William E.
    Homstad, Alison
    Hall, Gentzon
    Wu, Guanghong
    Nagaraj, Shashi
    Wigfall, Delbert
    Foreman, John
    Winn, Michelle P.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (07): : 1701 - 1710
  • [13] Childhood nephrotic syndrome-current and future therapies
    Greenbaum, Larry A.
    Benndorf, Rainer
    Smoyer, William E.
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (08) : 445 - 458
  • [14] The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome
    Hussain, Neesha
    Zello, J. Anastasia
    Vasilevska-Ristovska, Jovanka
    Banh, Tonny M.
    Patel, Viral P.
    Patel, Pranali
    Battiston, Christopher D.
    Hebert, Diane
    Licht, Christoph P. B.
    Piscione, Tino D.
    Parekh, Rulan S.
    [J]. BMC NEPHROLOGY, 2013, 14
  • [15] RACIAL-DIFFERENCES IN THE INCIDENCE AND RENAL OUTCOME OF IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN CHILDREN
    INGULLI, E
    TEJANI, A
    [J]. PEDIATRIC NEPHROLOGY, 1991, 5 (04) : 393 - 397
  • [16] MYH9 is associated with nondiabetic end-stage renal disease in African Americans
    Kao, W. H. Linda
    Klag, Michael J.
    Meoni, Lucy A.
    Reich, David
    Berthier-Schaad, Yvette
    Li, Man
    Coresh, Josef
    Patterson, Nick
    Tandon, Arti
    Powe, Neil R.
    Fink, Nancy E.
    Sadler, John H.
    Weir, Matthew R.
    Abboud, Hanna E.
    Adler, Sharon G.
    Divers, Jasmin
    Iyengar, Sudha K.
    Freedman, Barry I.
    Kimmel, Paul L.
    Knowler, William C.
    Kohn, Orly F.
    Kramp, Kristopher
    Leehey, David J.
    Nicholas, Susanne B.
    Pahl, Madeleine V.
    Schelling, Jeffrey R.
    Sedor, John R.
    Thornley-Brown, Denyse
    Winkler, Cheryl A.
    Smith, Michael W.
    Parekh, Rulan S.
    [J]. NATURE GENETICS, 2008, 40 (10) : 1185 - 1192
  • [17] Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome
    Kemper, MJ
    Altrogge, H
    Ludwig, K
    Timmermann, K
    Müller-Wiefel, DE
    [J]. PEDIATRIC NEPHROLOGY, 2000, 14 (8-9) : 772 - 775
  • [18] Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience
    Kim, J.
    Patnaik, N.
    Chorny, N.
    Frank, R.
    Infante, L.
    Sethna, C.
    [J]. NEPHRON EXTRA, 2014, 4 (01): : 8 - 17
  • [19] MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
    Kopp, Jeffrey B.
    Smith, Michael W.
    Nelson, George W.
    Johnson, Randall C.
    Freedman, Barry I.
    Bowden, Donald W.
    Oleksyk, Taras
    McKenzie, Louise M.
    Kajiyama, Hiroshi
    Ahuja, Tejinder S.
    Berns, Jeffrey S.
    Briggs, William
    Cho, Monique E.
    Dart, Richard A.
    Kimmel, Paul L.
    Korbet, Stephen M.
    Michel, Donna M.
    Mokrzycki, Michele H.
    Schelling, Jeffrey R.
    Simon, Eric
    Trachtman, Howard
    Vlahov, David
    Winkler, Cheryl A.
    [J]. NATURE GENETICS, 2008, 40 (10) : 1175 - 1184
  • [20] APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
    Kopp, Jeffrey B.
    Nelson, George W.
    Sampath, Karmini
    Johnson, Randall C.
    Genovese, Giulio
    An, Ping
    Friedman, David
    Briggs, William
    Dart, Richard
    Korbet, Stephen
    Mokrzycki, Michele H.
    Kimmel, Paul L.
    Limou, Sophie
    Ahuja, Tejinder S.
    Berns, Jeffrey S.
    Fryc, Justyna
    Simon, Eric E.
    Smith, Michael C.
    Trachtman, Howard
    Michel, Donna M.
    Schelling, Jeffrey R.
    Vlahov, David
    Pollak, Martin
    Winkler, Cheryl A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (11): : 2129 - 2137